Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry.
Bühler K, Roeder C, Schwarze JE, Lispi M, Allignol A, Falla E, Lukyanov V, D Hooghe T, Fischer R. Bühler K, et al. Among authors: roeder c. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):188-202. doi: 10.1016/j.bpobgyn.2022.02.002. Epub 2022 Feb 16. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35304097 Free article.
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers.
Schwarze JE, Venetis C, Iniesta S, Falla E, Lukyanov V, de Agustin Calvo E, D Hooghe T, Roeder C, Matorras R. Schwarze JE, et al. Among authors: roeder c. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):203-216. doi: 10.1016/j.bpobgyn.2022.01.011. Epub 2022 Feb 8. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35227619 Free article. Review.
Evaluation of costs associated with fertility treatment leading to a live birth after one fresh transfer: A global perspective.
Matorras R, Chaudhari VS, Roeder C, Schwarze JE, Bühler K, Hwang K, Chang-Woo C, Iniesta S, D'Hooghe T, Mathur R. Matorras R, et al. Among authors: roeder c. Best Pract Res Clin Obstet Gynaecol. 2023 Jul;89:102349. doi: 10.1016/j.bpobgyn.2023.102349. Epub 2023 May 18. Best Pract Res Clin Obstet Gynaecol. 2023. PMID: 37327667 Free article. Review.
A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS).
Borget I, Benchaib M, Poignant P, Rey L, Harty G, Chaudhari V, D'hooghe T, Schwarze JE, Cedrin Durnerin I, Roeder C, Grynberg M. Borget I, et al. Among authors: roeder c. Gynecol Obstet Invest. 2024 Nov 19:1-15. doi: 10.1159/000542074. Online ahead of print. Gynecol Obstet Invest. 2024. PMID: 39561733 Free article.
A letter to editor - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France.".
Schwarze JE, Chaudhari V, Montenegro S, Castello-Bridoux C, Masseria C, Roeder C. Schwarze JE, et al. Among authors: roeder c. Eur J Obstet Gynecol Reprod Biol X. 2024 Aug 2;23:100332. doi: 10.1016/j.eurox.2024.100332. eCollection 2024 Sep. Eur J Obstet Gynecol Reprod Biol X. 2024. PMID: 39220094 Free PMC article. No abstract available.
Critical appraisal on "Assessing the cost-effectiveness of once-weekly somatrogon vs. daily somatropin for pediatric growth hormone deficiency".
Masseria C, Roeder C. Masseria C, et al. Among authors: roeder c. J Med Econ. 2024 Jan-Dec;27(1):907-909. doi: 10.1080/13696998.2024.2374644. Epub 2024 Jul 8. J Med Econ. 2024. Update in: J Med Econ. 2024 Jan-Dec;27(1):1329-1331. doi: 10.1080/13696998.2024.2401282 PMID: 38957049 Free article. Updated. No abstract available.
70 results